First Mercantile Trust Co. lowered its stake in Envision Healthcare Corporation (NYSE:EVHC) by 36.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 5,895 shares of the company’s stock after selling 3,345 shares during the period. First Mercantile Trust Co.’s holdings in Envision Healthcare Corporation were worth $369,000 as of its most recent filing with the SEC.
Other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. boosted its stake in Envision Healthcare Corporation by 4.0% in the first quarter. Vanguard Group Inc. now owns 11,266,818 shares of the company’s stock valued at $690,881,000 after buying an additional 433,593 shares during the period. Wellington Management Group LLP boosted its stake in Envision Healthcare Corporation by 1.2% in the first quarter. Wellington Management Group LLP now owns 9,512,290 shares of the company’s stock valued at $583,294,000 after buying an additional 108,389 shares during the period. BlackRock Inc. boosted its stake in Envision Healthcare Corporation by 3,895.0% in the first quarter. BlackRock Inc. now owns 7,197,631 shares of the company’s stock valued at $441,359,000 after buying an additional 7,017,467 shares during the period. State Street Corp boosted its stake in Envision Healthcare Corporation by 4.1% in the first quarter. State Street Corp now owns 4,862,721 shares of the company’s stock valued at $298,178,000 after buying an additional 193,547 shares during the period. Finally, Janus Capital Management LLC boosted its stake in Envision Healthcare Corporation by 63.7% in the first quarter. Janus Capital Management LLC now owns 2,712,066 shares of the company’s stock valued at $167,536,000 after buying an additional 1,055,014 shares during the period. Institutional investors and hedge funds own 64.75% of the company’s stock.
Envision Healthcare Corporation (EVHC) opened at 49.88 on Friday. The stock’s market cap is $5.84 billion. Envision Healthcare Corporation has a 1-year low of $49.82 and a 1-year high of $74.75. The stock has a 50 day moving average price of $58.00 and a 200-day moving average price of $60.59.
Envision Healthcare Corporation (NYSE:EVHC) last posted its earnings results on Monday, August 7th. The company reported $0.79 EPS for the quarter, beating the Zacks’ consensus estimate of $0.75 by $0.04. Envision Healthcare Corporation had a positive return on equity of 5.35% and a negative net margin of 7.35%. The firm had revenue of $1.95 billion for the quarter, compared to analysts’ expectations of $1.96 billion. During the same period last year, the firm earned $0.34 EPS. The company’s quarterly revenue was up 156.7% on a year-over-year basis. On average, equities analysts expect that Envision Healthcare Corporation will post $1.40 EPS for the current year.
WARNING: “First Mercantile Trust Co. Sells 3,345 Shares of Envision Healthcare Corporation (EVHC)” was first published by Community Financial News and is the property of of Community Financial News. If you are viewing this news story on another site, it was stolen and reposted in violation of international trademark & copyright law. The original version of this news story can be read at https://www.com-unik.info/2017/08/18/first-mercantile-trust-co-sells-3345-shares-of-envision-healthcare-corporation-evhc.html.
Several equities research analysts have weighed in on EVHC shares. Cantor Fitzgerald reiterated a “buy” rating and issued a $80.00 price objective on shares of Envision Healthcare Corporation in a report on Tuesday, July 4th. Zacks Investment Research upgraded Envision Healthcare Corporation from a “strong sell” rating to a “buy” rating and set a $70.00 price objective for the company in a report on Tuesday, July 4th. Royal Bank Of Canada reiterated a “buy” rating and issued a $72.00 price objective on shares of Envision Healthcare Corporation in a report on Monday, June 5th. Jefferies Group LLC reiterated a “buy” rating and issued a $71.00 price objective (down previously from $75.00) on shares of Envision Healthcare Corporation in a report on Wednesday, May 3rd. Finally, Mizuho dropped their price objective on Envision Healthcare Corporation from $70.00 to $60.00 and set a “neutral” rating for the company in a report on Tuesday, May 30th. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and an average price target of $71.56.
In related news, insider Robert Jon Coward sold 1,500 shares of the firm’s stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $62.69, for a total value of $94,035.00. Following the transaction, the insider now directly owns 97,863 shares of the company’s stock, valued at approximately $6,135,031.47. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 3.10% of the stock is owned by company insiders.
About Envision Healthcare Corporation
Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.
What are top analysts saying about Envision Healthcare Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Envision Healthcare Corporation and related companies.